Myriad Genetics MYGN Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Myriad Genetics in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Myriad Genetics's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Myriad Genetics's accrued expenses?
- Myriad Genetics (MYGN) reported accrued expenses of $39.8M in Q1 2026.
- How has Myriad Genetics's accrued expenses changed year-over-year?
- Myriad Genetics's accrued expenses decreased by 7.4% year-over-year, from $43M to $39.8M.
- What is the long-term trend for Myriad Genetics's accrued expenses?
- Over 5 years (2020 to 2025), Myriad Genetics's accrued expenses has grown at a -8.3% compound annual growth rate (CAGR), from $79.1M to $51.2M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.